Zentalis Pharmaceuticals, Inc. (ZNTL): Weighted Average Diluted Shares
71.87M
Year ended 2025-12-31
+10.8%
3-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 71.87M | +1.1% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | 71.08M | +8.7% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | 65.41M | +23.7% | 2026-03-26, From 2023-01-01 |
| 2022-12-31 | 52.86M | +23.8% | 2025-03-26, From 2022-01-01 |
| 2021-12-31 | 42.69M | n/c | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | 28.11M | n/c | 2023-03-01, From 2020-01-01 |
| 2019-12-31 | 5.60M | n/a | 2022-02-24, From 2019-01-01 |